Advances in IBD

Dr Miguel Regueiro offers updates on medical and surgical approaches to treating perianal Crohn's disease, as presented at the recent DDW 2026 meeting. See more here: hubs.ly/Q04gSwT00

The IBD conversations shaping what’s next are happening in ONE MONTH in Nashville. Treatment shifts. Tough Crohn’s cases. Where IL-23s actually fit. What’s changing next. If you’re not in the room, you’re catching up later. Be apart of it: hubs.ly/Q04gxdcR0

Don't miss Dr Stephen Hanauer's expert recap of key themes relating to IBD from Digestive Disease Week 2026. hubs.ly/Q04fSbjJ0

A new approach to treating #IBD. 🧪💊 For both Crohn’s disease and ulcerative colitis, new combination fixed-dose co-antibody therapy designed to target two inflammatory pathways simultaneously, outperformed standard biologics in the most difficult-to-treat patients. @IcahnMountSinai @CedarsSinaiGI #DDW2026

Great session @DDWMeeting Profile update showing true disease modification in Crohn’s with top down therapy at 5 years

Most #IBD meetings review data. #AIBDRegionals helps you use it. 🔹 Built for the full care team 🔹 Focused on real clinical decisions 🔹 Interactive sessions 🔹 Local insights, shared challenges If you're treating IBD patients in Portland, register today! hubs.ly/Q04fF9mq0

Portland IBD clinicians—before you lock in your plans this May… Make sure you're attending the event that delivers real clinical impact. Don’t settle. Join the leaders in #IBD education. Register: hubs.ly/Q04dYM-L0

Catch up with IBD Drive Time as host Raymond Cross, MD, talks with Dr Colleen Kelly about the increasing prevalence and incidence of obesity among patients with IBD and whether GLP-1s have a role in their care. hubs.ly/Q04cNtHY0 #IBD

Hear it directly from the faculty. @KatieFalloonMD & @JessPhilpottMD share why #AIBDRegionals Cincinnati is worth your time—and what you’ll take back to your practice. #IBD Join us next weekend: April 18-19 in Cincinnati! Register Today: hubs.ly/Q04b4xVP0

Drs Raymond Cross, Sara Horst, and Jordan Axelrad give their takes on the best abstracts presented at ECCO in the latest IBD Drive Time. Check it out here: hubs.ly/Q048GzNY0

@Marylandibddoc proudly serves as Co-Chair of #AIBDRegionals with @tinahamd bringing high-impact #IBD education directly to clinicians. Join us in Cincinnati for expert-led sessions, case-based studies & actionable insights you can use right away! Register hubs.ly/Q047P_2z0

What will you actually learn at #AIBDRegionals Cincinnati? From IL-23 inhibitors to complicated Crohn’s, biomarker-driven care to women’s health—this is real-world #IBD education you can use immediately. Secure Your Spot Today: hubs.ly/Q047r-0q0

Check out the latest IBD Drive Time as Drs Raymond Cross and Shirley Cohen Mekelburg talk about how to help patients with IBD learn and apply self-care practices to control their disease: hubs.ly/Q047jq-l0

Join #AIBD2026, Dec 7-9 in Orlando, at the lowest price of the year! Rates expire April 17. Attend pre-conference workshops, explore dedicated tracks & connect with the #IBD community. Lock in your rate today: hubs.ly/Q047djTM0 @MRegueiroMD @MLongMD @DrCoreySiegel

High-level #IBD education is coming to Cincinnati on April 18-19. Don’t miss 2 days of focused, case-based #IBD education. Crohn’s & UC updates. Treatment optimization. High-impact clinical topics. CME credits. Spots are limited — secure yours today: hubs.ly/Q046xQsJ0

Nominations for The Sherman Prize open this Monday, March 16! Who will you nominate?

Patients with IBD have a higher risk of colorectal cancer. Drs James Lewis from University of Pennsylvania and Raymond Cross from Mercy Medical Center discuss when and how to surveil patients for dysplasia in the newest IBD Drive Time podcast: hubs.ly/Q044CH-M0 #IBD

In this IBD Drive Time, Drs Raymond Cross recaps key issues addressed in his AIBD presentation on complications of ostomy, with Dr Sara Horst in the host's seat. Listen in now! hubs.ly/Q03-FMwg0

Amy Masters, NP, reviews the post-hoc analysis of the LIBERTY study in Crohn's disease for Zymfentra, a subcutaneous formulation of infliximab, and how sub-q administration benefits patients with IBD. Check it out here: hubs.ly/Q03ZRqvh0

@saia_gi This is what the exhibit hall is all about! Thank you for bringing the energy and creativity to #AIBD with an interactive and engaging booth that truly enhanced the attendee experience.